WHITEHOUSE STATION, N.J. - (Mealey's) Merck and Co. Inc.
will pay $688 million to settle two securities class action lawsuits filed in
New Jersey federal court alleging that the drug maker and others failed to
disclose adverse results of a clinical trial for two cholesterol drugs Merck
In what may be the largest settlement ever in securities
class action litigation involving a pharmaceutical company, Merck has agreed to
a combined settlement of $688 million to settle two related securities class
action cases. The company's February 14, 2013 press release announcing the